HB 633 Maryland House of Delegates · 2026 Regular Session

Health Insurance - Ovarian Cancer Prevention With Salpingectomy - Required Coverage

HB 633 requires Maryland health insurers, nonprofit health plans, and health maintenance organizations to cover salpingectomy (surgical removal of fallopian tubes) as a preventive measure for ovarian cancer. It prohibits these insurers from charging copayments, coinsurance, or deductibles for this specific procedure, ensuring no out-of-pocket costs for covered individuals. The exception applies only to high-deductible health plans under federal law, allowing the deductible to apply to the procedure in those cases. This law directly affects women eligible for preventive care and the health insurance providers operating in Maryland.

Issues: ✓ Healthcare

Bill status passed 3 of 5 stages cleared

Introduction

Jan 2026

Committee Review

Apr 2026

House of Delegates Passage

Apr 2026

Senate Passage

Governor

Introduced Jan 30, 2026 Last action Apr 13, 2026

Maddy AI version diff · 1 comparison

What changed between versions

First - Health Insurance - Ovarian Cancer Prevention With Salpingectomy - Required Coverage and Prohibited Cost Sharing → Third - Health Insurance - Ovarian Cancer Prevention With Salpingectomy - Required Coverage · 4 edits

MODERATE

The bill was amended to add multiple sponsors and include a favorable committee report, indicating it has passed the House. The text was reorganized to insert new sections regarding a mandated benefits study and effective dates between the original sections. The core requirement for insurers to cover salpingectomies remains, though the language was slightly adjusted to specify 'opportunistic' salpingectomy coverage.

Scope change

The bill's scope regarding the study and effective dates was expanded by inserting new sections, while the primary mandate for coverage remains unchanged.

TECHNICAL

Added a list of additional sponsors (Terrasa, Bagnall, Cullison, Guzzone, Hutchinson, S. Johnson, Kipke, Lopez, Martinez, Reilly, Rosenberg, Ross, Taveras, White Holland, and Woorman) and a favorable committee report status.

REQUIREMENT

Inserted a new requirement for the Maryland Health Care Commission to conduct a mandated benefits study on non-opportunistic salpingectomy coverage and report findings to specific committees by December 1, 2026.

TIMELINE

Reorganized the effective date sections; the original Section 2 regarding the 2027 effective date was moved and renumbered, and a new Section 5 was added to set an effective date of July 1, 2026, for the Act generally.

DEFINITION

Modified the description of required coverage to explicitly include 'opportunistic salpingectomy coverage' and added language allowing deductibles to apply if the patient is on a high-deductible health plan.

Floor votes · House of Delegates Mar 31, 2026

How they voted

127–8

Passed · 7 other

Total votes 142

Mar 31, 2026

D Democratic103

99 Yea 4

96% Yea

R Republican39

28 Yea 8 Nay 3

71% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 13, 2026

Committee

Referred Rules

upper

Apr 13, 2026

Lower · Passed

Third Reading Passed

lower

Apr 13, 2026

Lower · Passed

Favorable with Amendments {

lower

Apr 11, 2026

Lower · Passed

Favorable with Amendments Report by Health

lower

Mar 31, 2026

House Of Delegates · Passed

House of Delegates Vote: pass (127-8-7)

house of delegates

Jan 30, 2026

Committee

First Reading Health

lower

16 primary · 0 co-sponsors